Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply

Andrea Mazzanti^{1

2

3}, Alessandro Trancuccio^{1

2

3}, Deni Kukavica^{1

2

3}, Eleonora Pagan⁴, Meng Wang⁵, Muhammed Mohsin¹, Derick Peterson⁵, Vincenzo Bagnardi⁴, Wojciech Zareba⁶, Silvia G Priori^{1

2

3}

Affiliations

¹ Molecular Cardiology, Istituti Clinici Scientifici Maugeri, IRCCS, Via Maugeri, 10, Pavia 27100, Italy.
² Department of Molecular Medicine, University of Pavia, Pavia, Italy.
³ Molecular Cardiology, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
⁴ Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
⁵ Department of Computational Biology and Biostatistics, University of Rochester, Rochester, NY, USA.
⁶ Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, 265 Crittenden Blvd., CU 420653, NY 14642, USA.

Editorial

Andrea Mazzanti et al. Europace. 2022.

. 2022 Apr 5;24(4):698-699.

doi: 10.1093/europace/euac013.

¹ Molecular Cardiology, Istituti Clinici Scientifici Maugeri, IRCCS, Via Maugeri, 10, Pavia 27100, Italy.
² Department of Molecular Medicine, University of Pavia, Pavia, Italy.
³ Molecular Cardiology, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
⁴ Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
⁵ Department of Computational Biology and Biostatistics, University of Rochester, Rochester, NY, USA.
⁶ Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, 265 Crittenden Blvd., CU 420653, NY 14642, USA.

No abstract available

Comment in

Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment.
Marathe K, Marwood OEG, Ahmad M. Marathe K, et al. Europace. 2022 Apr 5;24(4):697-698. doi: 10.1093/europace/euac012. Europace. 2022. PMID: 35303093 No abstract available.

Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk).
Mazzanti A, Trancuccio A, Kukavica D, Pagan E, Wang M, Mohsin M, Peterson D, Bagnardi V, Zareba W, Priori SG. Mazzanti A, et al. Europace. 2022 Apr 5;24(4):614-619. doi: 10.1093/europace/euab238. Europace. 2022. PMID: 34505884
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment.
Marathe K, Marwood OEG, Ahmad M. Marathe K, et al. Europace. 2022 Apr 5;24(4):697-698. doi: 10.1093/europace/euac012. Europace. 2022. PMID: 35303093 No abstract available.